PFPG
AZN icon

Pinnacle Financial Partners (Georgia)’s AstraZeneca AZN Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.68M Buy
51,065
+4,802
+10% +$903K 0.07% 217
2026
Q1 		$9.12M Buy
46,263
+4,367
+10% +$842K 0.07% 220
2025
Q4 		$7.7M Buy
+41,896
New +$7.35M 0.06% 240

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s AZN Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) increased its AstraZeneca (AZN) stake by 10% in Q2 2026, buying an estimated $903K and bringing the position to 51,065 shares worth $9.68M. The position accounts for 0.07% of the portfolio, ranked #217.

Pinnacle Financial Partners (Georgia) first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 51,065 shares of AstraZeneca worth $9.68M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) bought 4,802 AstraZeneca shares in Q2 2026, an estimated $903K.
  • AstraZeneca made up 0.07% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #217 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.